Cargando…

Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming

Detalles Bibliográficos
Autores principales:	Márquez, Javier, Matés, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830791/ https://www.ncbi.nlm.nih.gov/pubmed/33467031 http://dx.doi.org/10.3390/cancers13020314

Ejemplares similares

Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
por: Li, Yin, et al.
Publicado: (2021)

Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
por: Han, Jingjing, et al.
Publicado: (2021)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities
por: Alcaraz, Jordi, et al.
Publicado: (2021)

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
por: Ge, Tongxin, et al.
Publicado: (2022)

Metabolic Reprogramming and Vulnerabilities in Cancer
por: Lyssiotis, Costas A., et al.
Publicado: (2019)

Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities
por: Neitzel, Carina, et al.
Publicado: (2020)

Metabolic reprogramming in cervical cancer and metabolomics perspectives
por: Li, Boning, et al.
Publicado: (2021)

Editorial: Metabolic reprogramming and cancer progression
por: Yin, Qinan, et al.
Publicado: (2022)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
por: Pang, Yuyang, et al.
Publicado: (2023)

IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer
por: Sánchez-Aragó, María, et al.
Publicado: (2012)

Metabolic Reprogramming of Breast Tumor-Educated Macrophages Revealed by NMR Metabolomics
por: Dias, Ana S., et al.
Publicado: (2023)

Metabolic Reprogramming in Health and Disease
por: Chiellini, Grazia
Publicado: (2020)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

Metabolomics of oncogene-specific metabolic reprogramming during breast cancer
por: Dai, Chen, et al.
Publicado: (2018)

Corruptive Reprograming of Macrophages into Tumor-Associated Macrophages: The Transcriptional, Epigenetic and Metabolic Basis
por: Ahmad, Aamir
Publicado: (2023)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer
por: Wang, Fukai, et al.
Publicado: (2023)

Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy
por: Sun, Nai-Yun, et al.
Publicado: (2020)

Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities
por: Masson, Jesse JR, et al.
Publicado: (2017)

Novel Therapeutic Targets for Tumor Microenvironment in Cancer
por: Bei, Roberto, et al.
Publicado: (2023)

Special Issue on “The Application of Metabolomics in Clinical Practice: Challenges and Opportunities”
por: Mussap, Michele
Publicado: (2022)

Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
por: Huang, Mingyao, et al.
Publicado: (2020)

The Juggernaut of Adaptive Metabolism in Cancers: Implications and Therapeutic Targets
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2022)

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
por: Jin, Hao-Ran, et al.
Publicado: (2023)

Circular RNA: The main regulator of energy metabolic reprogramming in cancer cells
por: Zhang, Liyi
Publicado: (2019)

Metabolomics Deciphered Metabolic Reprogramming Required for Biofilm Formation
por: Lu, Haitao, et al.
Publicado: (2019)

Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities
por: Mattei, Fabrizio, et al.
Publicado: (2022)

Metabolic reprogramming of myeloid-derived suppressive cells
por: Du, Hong, et al.
Publicado: (2017)

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
por: Gandhi, Nishant, et al.
Publicado: (2019)

Targeting Metabolic Reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach
por: Draguet, Anaïs, et al.
Publicado: (2021)

Obesity paradox and lung cancer, metformin-based therapeutic opportunity?
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
por: Mostafavi, Samaneh, et al.
Publicado: (2022)

Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2015)

Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis
por: Jing, Chenzhi, et al.
Publicado: (2020)

TLR8 reprograms human Treg metabolism and function
por: Liu, Xia, et al.
Publicado: (2019)

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
por: Zheng, Xuewei, et al.
Publicado: (2022)

Lipid Metabolism as a Therapeutic Target
por: Smith, Terry K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3gs9b45arperm8nci86v0up6vm